Jagsonpal Pharmaceuticals Acquires Group Pharma Wellness Portfolio For Rs46.7 Crore

Acquired Wellness Portfolio of Group Pharmaceuticals via slump sale for Rs23.7cr upfront plus up to Rs23cr linked to FY28 sales, capped at Rs46.7cr. Portfolio of wellness products focused on women's healthcare with FY26 revenue of Rs24.6cr. Completion by 1 Nov 2026.